leisure time -WSS

leisure time

author：explore 2025-09-30 17:29:38 - browse：1

Photo of an arrangement of aspirin pills — Patrick Sison/AP

Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found.

The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD. One group was given baby aspirin daily for six months, while the other received a placebo pill. At the end of the study period, the aspirin group had reduced hepatic fat content while the placebo group had higher fat buildup.

MASLD (formerly known as non-alcoholic fatty liver disease) is a growing health threat, with 1 in 3 Americans having a troublesome amount of fat in their liver. The lipid buildup feeds into a toxic cycle of inflammation, tissue damage and, ultimately, irreversible scarring.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Senate panel passes drug pricing bills, but drops one PBM reform

hotspot

entertainment

WSS

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Argenx readies a blockbuster opportunity with drug for autoimmune disease

UnitedHealth increases loan offers after Change Healthcare outage

Baby aspirin cuts fat buildup in liver disease patients, in small study

Baby aspirin cuts fat buildup in liver disease patients, in small study

Sea level rise could wash away turtle breeding grounds around the world, researchers say

hotspot

leisure time

leisure time

Wildfire smoke exposes gaps in outdoor worker protections

The thinking behind the controversial eating disorder chatbot Tessa

Sports medicine is finally prioritizing gender equality

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Cancer drug shortages should be causing more outrage

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

Cancer drug shortages should be causing more outrage

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Supreme Court strikes down use of affirmative action

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

focus

Mom launches Girl Scout troop for LGBTQ youth in Texas

Neuroscience’s long legacy of racism

Stop the failed accountable care organization experiment

Methadone treatment changes are coming. Do they go far enough?

Reanimated hearts work just as well for transplants, study finds

Virtual Event: March of the Biosimilars

hotspot

entertainment

entertainment

focus